Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Hofmann

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Epidemiology|May 8, 2024
Prospective benchmarking of an observational analysis in the SWEDEHEART registry against the REDUCE-AMI randomized trialAnthony A Matthews, Issa J Dahebreh, Conor J MacDonald, et al.
Frontiers in Public Health|January 31, 2022
Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System-Insights From the Randomized DETO2X-AMI TrialRobin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, et al.
Diabetes Care|September 2, 2019
Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI TrialThomas Nyström, Stefan K James, Bertil Lindahl, et al.
American Heart Journal|December 8, 2022
Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registryMikolaj Skibniewski, Dimitrios Venetsanos, Anders Ahlsson, et al.
JACC. Cardiovascular Interventions|December 16, 2019
Effect of Oxygen Therapy on Cardiovascular Outcomes in Relation to Baseline Oxygen SaturationStefan K James, David Erlinge, Johan Herlitz, et al.
Helicobacter|March 16, 2026
Helicobacter pylori, Inflammation, and Long-Term Outcome in Patients With Acute Myocardial Infarction: A Prospective Cohort StudyMartin O Sundqvist, Jonatan Wärme, Marcus Hjort, et al.
European Heart Journal|September 11, 2019
Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registryMoa Simonsson, Lars Wallentin, Joakim Alfredsson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Inotropes and mortality in patients with cardiogenic shock: an instrumental variable analysis from the SWEDEHEART registryPetur Petursson, Thorsteinn Gudmundsson, Truls Råmunddal, et al.
Frontiers in Cardiovascular Medicine|April 1, 2021
Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction-Insights From the Randomized DETO2X-AMI TrialRobin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, et al.
American Heart Journal|March 29, 2025
HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Epidemiology|May 8, 2024
Prospective benchmarking of an observational analysis in the SWEDEHEART registry against the REDUCE-AMI randomized trialAnthony A Matthews, Issa J Dahebreh, Conor J MacDonald, et al.
Frontiers in Public Health|January 31, 2022
Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System-Insights From the Randomized DETO2X-AMI TrialRobin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, et al.
Diabetes Care|September 2, 2019
Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI TrialThomas Nyström, Stefan K James, Bertil Lindahl, et al.
American Heart Journal|December 8, 2022
Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registryMikolaj Skibniewski, Dimitrios Venetsanos, Anders Ahlsson, et al.
JACC. Cardiovascular Interventions|December 16, 2019
Effect of Oxygen Therapy on Cardiovascular Outcomes in Relation to Baseline Oxygen SaturationStefan K James, David Erlinge, Johan Herlitz, et al.
Helicobacter|March 16, 2026
Helicobacter pylori, Inflammation, and Long-Term Outcome in Patients With Acute Myocardial Infarction: A Prospective Cohort StudyMartin O Sundqvist, Jonatan Wärme, Marcus Hjort, et al.
European Heart Journal|September 11, 2019
Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registryMoa Simonsson, Lars Wallentin, Joakim Alfredsson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Inotropes and mortality in patients with cardiogenic shock: an instrumental variable analysis from the SWEDEHEART registryPetur Petursson, Thorsteinn Gudmundsson, Truls Råmunddal, et al.
Frontiers in Cardiovascular Medicine|April 1, 2021
Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction-Insights From the Randomized DETO2X-AMI TrialRobin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, et al.
American Heart Journal|March 29, 2025
HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Pageof 8